These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 11056762)
1. Relationship between the occurrence of anti-SSA, anti-SSB autoantibodies and HLA class II alleles from the aspect of in vitro inhibitory effect of glucocorticosteroid on the antibody-dependent cellular cytotoxicity in patients with primary Sjögren's syndrome. Kovács A; Szekeres E; Berek L; Endreffy E; Kovács L; Makula E; Eller J; Pokorny G; Petri IB Acta Microbiol Immunol Hung; 2000; 47(4):421-31. PubMed ID: 11056762 [TBL] [Abstract][Full Text] [Related]
2. In primary Sjögren's syndrome, HLA class II is associated exclusively with autoantibody production and spreading of the autoimmune response. Gottenberg JE; Busson M; Loiseau P; Cohen-Solal J; Lepage V; Charron D; Sibilia J; Mariette X Arthritis Rheum; 2003 Aug; 48(8):2240-5. PubMed ID: 12905478 [TBL] [Abstract][Full Text] [Related]
3. Association of severe inflammatory polyarthritis in primary Sjögren's syndrome: clinical, serologic, and HLA analysis. Mohammed K; Pope J; Le Riche N; Brintnell W; Cairns E; Coles R; Bell DA J Rheumatol; 2009 Sep; 36(9):1937-42. PubMed ID: 19487261 [TBL] [Abstract][Full Text] [Related]
4. True primary Sjögren's syndrome in a subset of patients with hepatitis C infection: a model linking chronic infection to chronic sialadenitis. De Vita S; Damato R; De Marchi G; Sacco S; Ferraccioli G Isr Med Assoc J; 2002 Dec; 4(12):1101-5. PubMed ID: 12516900 [TBL] [Abstract][Full Text] [Related]
5. Adult heart block is associated with disease activity in primary Sjögren's syndrome. Lodde BM; Sankar V; Kok MR; Leakan RA; Tak PP; Pillemer SR Scand J Rheumatol; 2005; 34(5):383-6. PubMed ID: 16234186 [TBL] [Abstract][Full Text] [Related]
6. Determination of the subset of Sjogren's syndrome with articular manifestations by anticyclic citrullinated peptide antibodies. Iwamoto N; Kawakami A; Tamai M; Fujikawa K; Arima K; Aramaki T; Kawashiri S; Ichinose K; Kamachi M; Nakamura H; Origuchi T; Ida H; Eguchi K J Rheumatol; 2009 Jan; 36(1):113-5. PubMed ID: 19132785 [TBL] [Abstract][Full Text] [Related]
7. Assessment of SS-A and SS-B in parotid saliva of patients with Sjögren's syndrome. Hammi AR; Al-Hashimi IH; Nunn ME; Zipp M J Oral Pathol Med; 2005 Apr; 34(4):198-203. PubMed ID: 15752253 [TBL] [Abstract][Full Text] [Related]
8. Sjögren's syndrome associated with systemic lupus erythematosus: clinical and laboratory profiles and comparison with primary Sjögren's syndrome. Manoussakis MN; Georgopoulou C; Zintzaras E; Spyropoulou M; Stavropoulou A; Skopouli FN; Moutsopoulos HM Arthritis Rheum; 2004 Mar; 50(3):882-91. PubMed ID: 15022331 [TBL] [Abstract][Full Text] [Related]
9. [Correlation of anti-60000 SSA antibody and anti-52000 SSA antibody with systemic lupus erythematosus and Sjögren's syndrome]. Zhang FC; Liu L; Xu D Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(1):7-10. PubMed ID: 17403303 [TBL] [Abstract][Full Text] [Related]
10. Association of transforming growth factor beta1 and tumor necrosis factor alpha polymorphisms with anti-SSB/La antibody secretion in patients with primary Sjögren's syndrome. Gottenberg JE; Busson M; Loiseau P; Dourche M; Cohen-Solal J; Lepage V; Charron D; Miceli C; Sibilia J; Mariette X Arthritis Rheum; 2004 Feb; 50(2):570-80. PubMed ID: 14872501 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between HLA D region gene and primary Sjögren's syndrome]. Fei H; Scharf S; Erlich H; Peebles C; Tan E; Fox R Zhonghua Yi Xue Za Zhi; 1991 Oct; 71(10):555-9, 38. PubMed ID: 1686576 [TBL] [Abstract][Full Text] [Related]
12. High prevalence of serum metabolic alterations in primary Sjögren's syndrome: influence on clinical and immunological expression. Ramos-Casals M; Brito-Zerón P; Sisó A; Vargas A; Ros E; Bove A; Belenguer R; Plaza J; Benavent J; Font J J Rheumatol; 2007 Apr; 34(4):754-61. PubMed ID: 17309127 [TBL] [Abstract][Full Text] [Related]
13. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study. Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737 [TBL] [Abstract][Full Text] [Related]
14. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus. Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372 [TBL] [Abstract][Full Text] [Related]